Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease.
<h4>Background</h4>Dual antiplatelet therapy (DAPT) is currently the standard treatment for the prevention of ischemic events after stent implantation. However, the optimal DAPT duration remains elusive for patients with chronic kidney disease (CKD). Therefore, we aimed to compare the ef...
Guardado en:
Autores principales: | Chih-Chin Kao, Mai-Szu Wu, Ming-Tsang Chuang, Yi-Cheng Lin, Chun-Yao Huang, Wei-Chiao Chang, Chih-Wei Chen, Tzu-Hao Chang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/afda8bca7355416db224ec85ebd112aa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease
por: Ying-Chang Tung, et al.
Publicado: (2020) -
Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
por: Dimitrios Alexopoulos, et al.
Publicado: (2020) -
From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease
por: Taylor C. Remillard MD, et al.
Publicado: (2021) -
Impact of preprocedural coronary flow grade on duration of dual antiplatelet therapy in acute myocardial infarction
por: Yong Hoon Kim, et al.
Publicado: (2021) -
Dual Antiplatelet Therapy in Coronary Artery Disease: Comparison Between ACC/AHA 2016 and ESC 2017 Guidelines
por: Christopher N Floyd
Publicado: (2020)